BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8831679)

  • 1. Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells.
    Yang MX; Cederbaum AI
    Biochem Biophys Res Commun; 1996 Sep; 226(3):711-6. PubMed ID: 8831679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1997 May; 341(1):25-33. PubMed ID: 9143349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 1999 Oct; 370(2):258-70. PubMed ID: 10510285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
    Goasduff T; Cederbaum AI
    Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
    Huan JY; Streicher JM; Bleyle LA; Koop DR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation and degradation of human cytochrome P4502E1 by CCl4 in a transfected HepG2 cell line.
    Dai Y; Cederbaum AI
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1614-22. PubMed ID: 8531136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1.
    Wu D; Cederbaum AI
    Alcohol Clin Exp Res; 1999 Jan; 23(1):67-76. PubMed ID: 10029205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycerol increases content and activity of human cytochrome P-4502E1 in a transduced HepG2 cell line by protein stabilization.
    Yang MX; Cederbaum AI
    Alcohol Clin Exp Res; 1997 Apr; 21(2):340-7. PubMed ID: 9113273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
    Wang Q; Theriault A; Gapor A; Adeli K
    Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome.
    Sirma H; Weil R; Rosmorduc O; Urban S; Israël A; Kremsdorf D; Bréchot C
    Oncogene; 1998 Apr; 16(16):2051-63. PubMed ID: 9572486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
    Yeung SJ; Chen SH; Chan L
    Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells.
    Pérez MJ; Cederbaum AI
    Hepatology; 2003 Jun; 37(6):1395-404. PubMed ID: 12774019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
    Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
    Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism.
    Wu H; Cai P; Clemens DL; Jerrells TR; Ansari GA; Kaphalia BS
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):238-47. PubMed ID: 16806343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.
    Marambaud P; Alves da Costa C; Ancolio K; Checler F
    Biochem Biophys Res Commun; 1998 Nov; 252(1):134-8. PubMed ID: 9813158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
    Zhukov A; Ingelman-Sundberg M
    Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W; Chang BH; Mancini M; Chan L
    J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosinase degradation via two pathways during reverse translocation to the cytosol.
    Mosse CA; Hsu W; Engelhard VH
    Biochem Biophys Res Commun; 2001 Jul; 285(2):313-9. PubMed ID: 11444844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.